BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22882693)

  • 1. Multidrug-resistant Klebsiella pneumoniae acquisition in lung transplant recipients.
    Raviv Y; Shitrit D; Amital A; Fox B; Bakal I; Tauber R; Bishara J; Kramer MR
    Clin Transplant; 2012; 26(4):E388-94. PubMed ID: 22882693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
    Kalpoe JS; Sonnenberg E; Factor SH; del Rio Martin J; Schiano T; Patel G; Huprikar S
    Liver Transpl; 2012 Apr; 18(4):468-74. PubMed ID: 22467548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
    Brizendine KD; Richter SS; Cober ED; van Duin D
    Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
    Simkins J; Muggia V; Cohen HW; Minamoto GY
    Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center.
    Filozov A; Visintainer P; Carbonaro C; Aguero-Rosenfeld M; Wormser GP; Montecalvo MA
    Am J Infect Control; 2009 Nov; 37(9):723-8. PubMed ID: 19501935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population.
    Rebuck JA; Olsen KM; Fey PD; Langnas AN; Rupp ME
    Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
    Lee CH; Su LH; Tang YF; Liu JW
    J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of extended spectrum beta-lactamase producing Klebsiella pneumoniae infections in severely burned patients.
    Bennett JW; Robertson JL; Hospenthal DR; Wolf SE; Chung KK; Mende K; Murray CK
    J Am Coll Surg; 2010 Sep; 211(3):391-9. PubMed ID: 20800197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallarés R; Liñares J; Ariza J; Gudiol F
    J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
    Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
    J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
    Viale P; Giannella M; Lewis R; Trecarichi EM; Petrosillo N; Tumbarello M
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1053-63. PubMed ID: 24073806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.
    Behar PR; Teixeira PJ; Fachel JM; Kalil AC
    J Hosp Infect; 2008 Feb; 68(2):123-9. PubMed ID: 18192077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study.
    Demir S; Soysal A; Bakir M; Kaufmann ME; Yagci A
    J Paediatr Child Health; 2008 Oct; 44(10):548-53. PubMed ID: 18557808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.
    Freire MP; Abdala E; Moura ML; de Paula FJ; Spadão F; Caiaffa-Filho HH; David-Neto E; Nahas WC; Pierrotti LC
    Infection; 2015 Jun; 43(3):315-23. PubMed ID: 25690848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.